Literature DB >> 32860162

Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.

Jovana Komazec1, Bojan Ristivojevic1, Branka Zukic1, Vera Zdravkovic2,3, Teodora Karan-Djurasevic1, Sonja Pavlovic1, Milena Ugrin4.   

Abstract

Maturity-onset diabetes of the young (MODY) is a form of monogenic diabetes caused by the variants in MODY-related genes. In addition to coding variants, variants in the promoter region of MODY-related genes can cause the disease as well. In this study, we screened the promoter regions of the most common MODY-related genes GCK, HNF1A, HNF4A and HNF1B in our cohort of 29 MODY patients. We identified one genetic variant in the HNF1A gene, a 7 bp insertion c.-154-160insTGGGGGT, and three variants in the GCK gene, -282C>T; -194A>G; 402C>G appearing as set. Chloramphenicol acetyltransferase (CAT) assay was performed to test the effect of the 7 bp insertion and the variant set on the activity of the reporter gene in HepG2 and RIN-5F cell, respectively, where a decreasing trend was observed for both variants. In silico analysis and electrophoretic mobility shift assay showed that the 7 bp insertion did not create the binding site for new transcriptional factors, but gave rise to additional binding sites for the existing ones. Results from our study indicated that the 7 bp insertion in the HNF1A gene could be associated with the patient's diabetes. As for the GCK variant set, it is probably not associated with diabetes in patients, but it may modify the fasting glucose level by causing small elevation in variant set carriers. We have presented two promoter variants in MODY-related genes. Variant in the HNF1A gene is presumed to be disease-causing and the GCK promoter variant set could be a phenotype modifier.

Entities:  

Keywords:  Functional analysis; GCK gene; HNF1A gene; Maturity-onset diabetes of the young (MODY); Promoter variants

Mesh:

Substances:

Year:  2020        PMID: 32860162     DOI: 10.1007/s11033-020-05734-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks.

Authors:  Rachana Haliyur; Xin Tong; May Sanyoura; Shristi Shrestha; Jill Lindner; Diane C Saunders; Radhika Aramandla; Greg Poffenberger; Sambra D Redick; Rita Bottino; Nripesh Prasad; Shawn E Levy; Raymond D Blind; David M Harlan; Louis H Philipson; Roland W Stein; Marcela Brissova; Alvin C Powers
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  Investigating maturity onset diabetes of the young.

Authors:  Ohn Nyunt; Joyce Y Wu; Ivan N McGown; Mark Harris; Tony Huynh; Gary M Leong; David M Cowley; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

3.  Practical Aspects of Monogenic Diabetes: A Clinical Point of View.

Authors:  Carl-Hugo Lachance
Journal:  Can J Diabetes       Date:  2016-02-18       Impact factor: 4.190

4.  Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.

Authors:  Lorna W Harries; Sian Ellard; Amanda Stride; Noel G Morgan; Andrew T Hattersley
Journal:  Hum Mol Genet       Date:  2006-06-07       Impact factor: 6.150

Review 5.  Monogenic diabetes mellitus due to defects in insulin secretion.

Authors:  Christoph Henzen
Journal:  Swiss Med Wkly       Date:  2012-10-04       Impact factor: 2.193

Review 6.  Glucokinase (GCK) mutations in hyper- and hypoglycemia: maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy.

Authors:  Anna L Gloyn
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

7.  Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.

Authors:  Kevin Colclough; Christine Bellanne-Chantelot; Cecile Saint-Martin; Sarah E Flanagan; Sian Ellard
Journal:  Hum Mutat       Date:  2013-04-02       Impact factor: 4.878

Review 8.  Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.

Authors:  Kara K Osbak; Kevin Colclough; Cecile Saint-Martin; Nicola L Beer; Christine Bellanné-Chantelot; Sian Ellard; Anna L Gloyn
Journal:  Hum Mutat       Date:  2009-11       Impact factor: 4.878

9.  Identification and functional characterisation of novel glucokinase mutations causing maturity-onset diabetes of the young in Slovakia.

Authors:  Lucia Valentínová; Nicola L Beer; Juraj Staník; Nicholas D Tribble; Martijn van de Bunt; Miroslava Hučková; Amy Barrett; Iwar Klimeš; Daniela Gašperíková; Anna L Gloyn
Journal:  PLoS One       Date:  2012-04-06       Impact factor: 3.240

Review 10.  Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment.

Authors:  Tatsuhiko Urakami
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-08       Impact factor: 3.168

View more
  1 in total

Review 1.  Stem Cell-Derived β Cells: A Versatile Research Platform to Interrogate the Genetic Basis of β Cell Dysfunction.

Authors:  Alberto Bartolomé
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.